Merck & Co Inc
Biden administration to release prices for first 10 drugs subject to landmark Medicare negotiations
Activists protest the price of prescription drug costs in front of the U.S. Department of Health and Human Services building in Washington, D.C., on Oct. 6, 2022. Anna Moneymaker | Getty Images The Biden administration on Thursday will release prices for the first 10 prescription drugs that were subject to landmark negotiations between drugmakers and […]
Read More
Moderna stock falls more than 10% as it slashes guidance on low EU sales, tough U.S. vaccine market
Moderna on Thursday reported second-quarter revenue that beat expectations but slashed its full-year sales guidance, citing lower expected sales in Europe, a “competitive environment” for respiratory vaccines in the U.S. and the potential for deferred international revenue into 2025. The biotech company now expects 2024 product revenue to come in between $3 billion to $3.5 […]
Read More
Stocks making the biggest moves midday: JetBlue, Sprouts Farmers Market, Varonis Systems and more
Check out the companies making headlines in midday trading: JetBlue — The airline soared almost 20% after reporting second-quarter earnings that beat analysts’ expectations . The New York City-based carrier posted adjusted earnings of 8 cents per share, excluding one-time items, compared to analysts’ estimated loss of 11 cents per share, according to LSEG. Revenue […]
Read More
Stocks making the biggest moves premarket: CrowdStrike, Merck, PayPal, JetBlue and more
Check out the companies making headlines in premarket trading. CrowdStrike — Shares slipped 5% after CNBC reported that stated Delta Airlines has retained legal counsel to pursue damages from both CrowdStrike and Microsoft following after a software update led to mass flight interruptions in July. Woodward — The aerospace and industrial equipment company slipped more […]
Read More
Merck beats earnings expectations, raises sales outlook on strong demand for top drugs like Keytruda
The exterior view of the entrance to Merck headquarters in Rahway, New Jersey, on Feb. 5, 2024. Spencer Platt | Getty Images Merck on Tuesday reported second-quarter revenue and adjusted earnings that topped Wall Street’s expectations as it saw strong sales from its blockbuster cancer drug Keytruda as well as other treatments in its oncology […]
Read More
Stock futures are flat in overnight trading ahead of key corporate earnings: Live updates
Traders on the floor of the New York Stock Exchange on Aug. 4, 2022. Source: NYSE Stock futures were flat in overnight trading Monday as investors awaited key corporate earnings and the beginning of the Federal Reserve’s policy meeting. Futures on the Dow Jones Industrial Average inched up 20 points. S&P 500 futures and Nasdaq […]
Read More
Here are JPMorgan’s top drug stock picks into earnings
JPMorgan is eyeing a few drug manufacturers ahead of their earnings reports as investors continue to sell out of major technology firms. Major market trends in the first half of 2024 have shifted and sparked a rotation out of large technology stocks into less-loved areas of the market, including value stocks and small caps. The […]
Read More
Healthy Returns: The first round of Medicare drug price negotiations is nearing an end
Activists protest the price of prescription drug costs in front of the U.S. Department of Health and Human Services building in Washington, D.C., on Oct. 6, 2022. Anna Moneymaker | Getty Images Think a friend or colleague should be getting this newsletter? Share this link with them to sign up. Good afternoon! The first round […]
Read More
Healthy Returns: Diabetes drug Ozempic may lower dementia risk, nicotine use
A box of Ozempic made by Novo Nordisk is seen at a pharmacy in London, Britain March 8, 2024. Hollie Adams | Reuters Think a friend or colleague should be getting this newsletter? Share this link with them to sign up. Good morning! Novo Nordisk‘s blockbuster diabetes drug Ozempic may have more to offer beyond […]
Read More
Morgan Stanley names its ‘highest conviction’ stock picks for Europe, giving 4 more than 30% upside
Morgan Stanley says it’s time for stock-picking in Europe as earnings season and rate cuts are imminent. The investment bank says stock-level dispersion and equities market breadth should rise from here. Stock-level dispersion refers to the range of returns for stocks, while market breadth tracks the number of stocks going up relative to those declining. […]
Read More